Incidence and clinical and immunological characteristics of primary Toxoplasma gondii infection in HIV-infected patients
Language English Country Canada Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
23669277
DOI
10.1016/j.ijid.2013.03.017
PII: S1201-9712(13)00146-X
Knihovny.cz E-resources
- Keywords
- HIV, Incidence, Primary infection, Seroconversion, Toxoplasma gondii,
- MeSH
- Adult MeSH
- HIV Antibodies blood MeSH
- HIV Seropositivity epidemiology immunology MeSH
- Incidence MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- AIDS-Related Opportunistic Infections epidemiology immunology MeSH
- CD4 Lymphocyte Count MeSH
- Retrospective Studies MeSH
- Toxoplasmosis epidemiology immunology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- HIV Antibodies MeSH
OBJECTIVES: To determine the incidence and laboratory characteristics of primary Toxoplasma gondii infection in HIV-infected individuals. METHODS: This retrospective study was conducted between 1988 and 2012 on a cohort of 1130 HIV-infected patients at the AIDS Center Prague. Toxoplasma serology, standard laboratory parameters, and health status were evaluated at 3-6-month intervals for all patients. RESULTS: The total person-time of follow-up of patients at risk of Toxoplasma seroconversion was 3046.3 years; there were 14 primary T. gondii infections, yielding an incidence rate of 0.0046 (95% confidence interval 0.0027-0.0078). Most of the subjects were clinically asymptomatic, but in one case seroconversion was accompanied by transient cervical lymphadenopathy. The CD4+ T-lymphocyte count geometric mean increased from 418 (95% confidence interval 303-579) cells/μl before seroconversion to 501 (95% confidence interval 363-691) cells/μl after seroconversion (p = 0.004), while other parameters (CD8+ T-lymphocytes, natural killer cells, viral load, beta2-microglobulin, total immunoglobulins) remained unchanged. As compared to the control group, patients with primary toxoplasmosis had higher initial levels of total immunoglobulins IgA and IgG and a tendency to higher CD8+ T lymphocyte counts. CONCLUSIONS: Neither the incidence nor the course of the primary Toxoplasma infection was influenced by the immune status of the patients. Immune parameters of patients with primary Toxoplasma infection did not differ from those of the controls.
References provided by Crossref.org